PHIO — PHIO PHARMACEUTICALS CORP
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $0 | — | -$8.4M | — | -97.7% | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.35 | — | -0.35 | -0.35 | 1 | +1 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -1.41 | — | -1.41 | -1.41 | 1 | +1 |
| Dec 2027 | -0.73 | — | -0.73 | -0.73 | 1 | +1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 26 SEC-registered investment managers reported holding PHIO (PHIO PHARMACEUTICALS CORP) in their latest 13F filings, with a combined reported value of $813.66K across 790.11K shares. That is +13.4% by share count (+83.71K shares) versus the previous quarter, while reported value moved +14.0%. Ownership is concentrated: the five largest holders account for 51.1% of reported value and the top ten for 85.6%.
Compared with the prior quarter, 4 opened new positions, 7 added to existing stakes, 7 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of PHIO PHARMACEUTICALS CORP (PHIO) include Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, ranked by reported 13F value among the 50 institutional holders on this page.
PHIO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 26 | 790.11K | $813.66K | +13.4% |
| Q2 2026 | 25 | 761.70K | $780.00K | -10.7% |
| Q1 2026 | 24 | 668.49K | $814.95K | +47.0% |
| Q4 2025 | 16 | 341.21K | $358.55K | +27.9% |
| Q3 2025 | 11 | 188.49K | $467.44K | +27.7% |
| Q2 2025 | 11 | 164.72K | $387.36K | +12.7% |
| Q1 2025 | 11 | 100.62K | $130.81K | +83.2% |
| Q4 2024 | 11 | 154.05K | $277.44K | +146.8% |
Over the 8 quarters shown, institutional share counts increased 413% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2024 (+146.8%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 105.69K | $108.86K | 0.00% | Reduce | |
| 94.26K | $97.09K | 0.00% | Hold | |
| 76.11K | $78.40K | 0.00% | Add | |
| 65.69K | $67.66K | 0.00% | Add | |
| 62.00K | $63.86K | 0.00% | Add | |
| 61.45K | $63.29K | 0.00% | Reduce | |
| 57.38K | $59.10K | 0.00% | New | |
| 56.06K | $57.74K | 0.00% | Add | |
| 50.00K | $51.50K | 0.00% | Hold | |
| 47.50K | $48.92K | 0.00% | Hold | |
| 27.82K | $28.66K | 0.00% | Add | |
| 25.05K | $25.80K | 0.00% | Reduce | |
| 21.48K | $22.00K | 0.00% | Add | |
| 12.36K | $12.73K | 0.00% | New | |
| 11.14K | $11.46K | 0.00% | New | |
| 6.00K | $6.18K | 0.00% | Hold | |
| 3.07K | $3.16K | 0.00% | Reduce | |
| 2.00K | $2.06K | 0.00% | Hold | |
| 2.00K | $2.06K | 0.00% | Add | |
| 1.68K | $1.73K | 0.00% | Reduce | |
| 1.25K | $1.28K | 0.00% | Hold | |
| 110 | $113 | 0.00% | Hold | |
| 9 | $9 | 0.00% | Hold | |
| 3 | $3 | 0.00% | Reduce | |
| 3 | $3 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 117.75K | $120.70K | 0.00% | Reduce | |
| 114.57K | $117.44K | 0.00% | New | |
| 114.57K | $117.44K | 0.00% | Reduce | |
| 94.26K | $96.62K | 0.00% | Add | |
| 50.00K | $51.00K | 0.00% | New | |
| 47.50K | $48.69K | 0.00% | Add | |
| 47.15K | $48.33K | 0.00% | New | |
| 38.17K | $39.12K | 0.00% | Hold | |
| 27.77K | $28.46K | 0.00% | Add | |
| 21.50K | $22.04K | 0.00% | Reduce | |
| 18.48K | $18.94K | 0.00% | Reduce | |
| 13.18K | $13.00K | 0.00% | Reduce | |
| 12.00K | $12.30K | 0.00% | New | |
| 11.61K | $11.89K | 0.00% | Add | |
| 10.00K | $10.25K | 0.00% | Hold | |
| 6.21K | $6.36K | 0.00% | Reduce | |
| 6.00K | $6.15K | 0.00% | Hold | |
| 5.39K | $5.52K | 0.00% | Reduce | |
| 2.00K | $2.06K | 0.00% | Hold | |
| 1.99K | $2.05K | 0.00% | Hold | |
| 1.25K | $1.28K | 0.00% | Add | |
| 231 | $237 | 0.00% | New | |
| 110 | $113 | 0.00% | Hold | |
| 9 | $9 | 0.00% | Hold | |
| 6 | $6 | 0.00% | Add |
Q1 2026 — 24 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 147.25K | $179.65K | 0.00% | Add | |
| 119.19K | $145.41K | 0.00% | New | |
| 79.85K | $97.42K | 0.00% | New | |
| 45.00K | $54.90K | 0.00% | Add | |
| 38.17K | $46.57K | 0.00% | New | |
| 34.73K | $42.00K | 0.00% | New | |
| 32.49K | $39.64K | 0.00% | Add | |
| 30.03K | $36.64K | 0.03% | New | |
| 26.99K | $32.92K | 0.00% | Add | |
| 24.87K | $30.34K | 0.00% | New | |
| 23.76K | $28.98K | 0.00% | Hold | |
| 19.86K | $24.00K | 0.00% | New | |
| 15.22K | $18.57K | 0.00% | New | |
| 10.00K | $12.20K | 0.00% | Hold | |
| 7.62K | $9.30K | 0.00% | New | |
| 6.00K | $7.32K | 0.00% | Hold | |
| 2.00K | $2.44K | 0.00% | New | |
| 2.00K | $2.44K | 0.00% | New | |
| 1.22K | $1.49K | 0.00% | Add | |
| 1.07K | $1.31K | 0.00% | New | |
| 1.02K | $1.25K | 0.00% | New | |
| 110 | $134 | 0.00% | Hold | |
| 9 | $11 | 0.00% | Hold | |
| 3 | $4 | 0.00% | New |
Q4 2025 — 16 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 92.64K | $97.27K | 0.00% | Add | |
| 87.63K | $92.01K | 0.00% | Hold | |
| 42.50K | $44.62K | 0.00% | Add | |
| 23.76K | $24.95K | 0.00% | New | |
| 20.09K | $21.10K | 0.00% | New | |
| 14.49K | $15.22K | 0.00% | New | |
| 11.83K | $12.42K | 0.00% | New | |
| 10.80K | $11.34K | 0.00% | New | |
| 10.21K | $11.00K | 0.00% | New | |
| 10.00K | $10.50K | 0.00% | New | |
| 8.59K | $9.02K | 0.00% | Add | |
| 6.00K | $6.30K | 0.00% | Hold | |
| 1.41K | $1.48K | 0.00% | Add | |
| 1.14K | $1.19K | 0.00% | Add | |
| 110 | $116 | 0.00% | Hold | |
| 9 | $9 | 0.00% | Hold |
Q3 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 87.63K | $217.32K | 0.00% | Add | |
| 57.91K | $143.60K | 0.00% | Hold | |
| 33.50K | $83.08K | 0.00% | Add | |
| 6.00K | $14.88K | 0.00% | Hold | |
| 1.40K | $3.47K | 0.00% | Add | |
| 1.10K | $2.73K | 0.00% | Reduce | |
| 413 | $1.02K | 0.00% | New | |
| 406 | $1.01K | 0.00% | New | |
| 110 | $273 | 0.00% | Hold | |
| 13 | $32 | 0.00% | New | |
| 9 | $22 | 0.00% | Hold |
Q2 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 57.69K | $135.58K | 0.00% | Add | |
| 48.66K | $114.36K | 0.00% | New | |
| 32.50K | $76.38K | 0.00% | Reduce | |
| 14.30K | $34.00K | 0.00% | New | |
| 6.00K | $14.10K | 0.00% | Hold | |
| 3.46K | $8.00K | 0.00% | New | |
| 1.91K | $4.49K | 0.00% | Add | |
| 110 | $259 | 0.00% | Hold | |
| 46 | $108 | 0.00% | Add | |
| 27 | $63 | 0.00% | New | |
| 9 | $21 | 0.00% | Hold |
New Positions (Q3 2026)
- Renaissance Technologies 57.38K sh · $59.10K
- TWO SIGMA SECURITIES, LLC 12.36K sh · $12.73K
- StoneX Group Inc. 11.14K sh · $11.46K
- Fidelity Management & Research (FMR) 3 sh · $3
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 114.57K sh · $117.44K
- Citigroup Inc sold 11.61K sh · $11.89K
- CAPTRUST FINANCIAL ADVISORS sold 10.00K sh · $10.25K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 105.69K | 114.57K | 147.25K | 92.64K | 57.91K | 57.69K | 41.59K | — | — | 28.14K | — | — | 15.23K | — | — | 106.92K | 107.19K | 107.19K | 107.19K | 107.19K |
| VANGUARD CAPITAL MANAGEMENT LLC | 94.26K | 94.26K | 79.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 76.11K | 38.17K | 38.17K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 65.69K | 47.15K | — | — | — | — | — | 44.53K | — | 21.69K | — | 31.84K | — | — | — | — | 11.60K | — | — | 62.40K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62.00K | 12.00K | — | — | — | — | — | — | — | 23.49K | 23.49K | 23.49K | 23.49K | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 61.45K | 117.75K | 119.19K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 57.38K | — | — | — | — | — | — | — | — | — | — | 21.06K | 19.71K | 11.28K | 14.28K | 166.80K | 213.60K | 234.85K | 41.50K | 10.10K |
| Two Sigma Investments | 56.06K | 21.50K | 32.49K | 14.49K | — | — | — | — | — | — | — | — | — | — | — | 22.40K | 23.20K | 27.79K | — | 128.72K |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 50.00K | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cetera Investment Advisers | 47.50K | 47.50K | 45.00K | 42.50K | 33.50K | 32.50K | 38.50K | 13.00K | — | 35.42K | 30.42K | 16.92K | 10.67K | — | — | — | — | — | — | — |
| XTX Topco Ltd | 27.82K | 18.48K | 24.87K | — | — | — | 10.80K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 25.05K | 27.77K | 23.76K | 23.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 21.48K | 13.18K | 34.73K | — | — | — | — | 42.34K | — | — | — | — | — | — | — | — | — | — | — | — |
| TWO SIGMA SECURITIES, LLC | 12.36K | — | 15.22K | — | — | — | — | — | — | 12.46K | — | — | — | — | — | — | — | — | — | — |
| StoneX Group Inc. | 11.14K | — | — | 11.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K | 5.91K | — | — | — | 125 | 125 | 125 | 125 | 1.50K | 1.50K | 1.50K | 1.51K | 1.50K |
| UBS Group AG | 3.07K | 5.39K | 26.99K | 8.59K | 13 | — | 103 | 2.40K | 1.69K | 2.45K | 1.36K | — | — | — | 207 | 23.03K | — | — | 2.69K | 7.00K |
| OSAIC HOLDINGS, INC. | 2.00K | 2.00K | 2.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Spire Wealth Management | 2.00K | 1.99K | 2.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 1.68K | 6.21K | 7.62K | — | 406 | — | 2.50K | 4.68K | 1.17K | 5.73K | 5.70K | 5.71K | 2.00K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold PHIO?
As of 2026-Q3, 26 institutional funds reported holding PHIO (PHIO PHARMACEUTICALS CORP) in SEC 13F filings, with a combined reported value of $813.66K.
How many shares of PHIO do institutions own?
13F filers reported 790.11K shares of PHIO, worth $813.66K in aggregate at the end of 2026-Q3.
Is institutional ownership of PHIO rising or falling?
Share counts moved +13.4% versus the prior quarter — accumulation.
Who are the top institutional holders of PHIO?
The largest 13F holders are Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of PHIO PHARMACEUTICALS CORP?
The major shareholders of PHIO PHARMACEUTICALS CORP (PHIO) by reported 13F value are Anson Funds Management LP, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, VANGUARD CAPITAL MANAGEMENT LLC, Vanguard Group, among 50 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.